A nursing-home quote can look complete while leaving one expensive medication unresolved. Since July 1, 2026, Medicare has offered temporary nationwide access to certain GLP-1 drugs through the Medicare GLP-1 Bridge program for eligible people with Medicare drug coverage. The program can change the pharmacy price of a covered prescription, but it does not turn a nursing-home admission offer into a medication guarantee.
Before accepting a bed, the family should separate four questions: whether the resident meets Bridge eligibility, whether the exact product is covered, which pharmacy will fill it, and which facility services appear on the nursing-home bill. The written comparison should also show what happens during prior authorization, after a drug change and if the resident is not eligible.
Confirm the exact drug and reason for treatment
Start with the current prescription, dosage form, dose, schedule and documented indication. Medicare lists Foundayo, Wegovy and only the KwikPen version of Zepbound under the Bridge program. It does not cover the single-dose Zepbound vials or pens through this program. A product name without its form is therefore not enough for a reliable quote.
The Bridge also excludes people whose Part D plan already covers their GLP-1 and directs certain conditions, including type 2 diabetes, moderate-to-severe sleep apnea and fatty liver disease, back to regular Part D coverage. Ask the prescriber and plan to identify the applicable route rather than assuming that every GLP-1 prescription uses the same benefit.
Test Medicare Bridge eligibility before admission
The resident must be at least 18, have Medicare drug coverage and meet the program's body-mass-index and health-condition criteria when starting therapy. Medicare describes different qualifying combinations for a BMI of 35 or higher, 30 or higher with specified conditions, and 27 or higher with specified cardiovascular or metabolic conditions.
Record the resident's coverage type, prescriber, qualifying facts and whether Medicare or the plan has confirmed the route. Do not send a complete medical history to a placement service or facility sales contact. The clinical and coverage details should go only to the people who need them for prescribing, authorization, pharmacy processing and care planning.
Price the pharmacy copayment separately
Medicare states that the Bridge copayment is $50 for a one-month supply of 28 or 30 days. Because the temporary program is separate from regular Part D coverage, that copayment does not count toward the plan deductible or out-of-pocket limit, does not appear on the Part D Explanation of Benefits or Medicare Summary Notice, cannot be reduced through Extra Help and cannot be spread through the Medicare Prescription Payment Plan.
Put this amount on its own line in the monthly model. Then ask the nursing home to identify every separate medication-related charge it expects, such as delivery, supplies, clinical services or administration that are not already included in the quoted rate. Do not combine the federal pharmacy copayment with a facility estimate and label the total a Medicare charge.
Verify the nursing home's pharmacy workflow
Federal nursing-home rules require a participating facility to provide or obtain routine and emergency drugs and to maintain procedures for accurate acquisition, receipt, dispensing and administration. The facility must also use a licensed pharmacist and arrange at least monthly review of each resident's drug regimen. Those duties do not prove that a particular outside pharmacy, delivery timetable or device will work on the admission date.
Ask which long-term-care pharmacy serves the unit, whether the resident may use another pharmacy, how refrigerated or injectable products are received and stored, who administers them, and what happens if the first dose is due before authorization is complete. Request a named contact for the prescriber, pharmacy and facility nurse so an unresolved handoff does not surface after move-in.
Map the prior-authorization timeline
Medicare says the prescriber must send the prescription to the pharmacy and, when requested, complete prior authorization. The provider must certify that the drug is part of a lifestyle program focused on diet and exercise. Approved authorization can remain valid through December 31, 2027, including refills and dose changes, unless the patient changes GLP-1 drugs.
Before transport is booked, establish who has submitted the request, what documentation is outstanding, how approval will be communicated and which pharmacy will process it. A letter that coverage is approved is different from confirmation that stock is available and the first dose can be administered at the facility.
Compare offers using one medication-cost schedule
Give each shortlisted home the same questions. Record the base room and care rate, pharmacy used, medication-management inclusions, delivery or supply charges, administration arrangements, storage capability and the plan for a missed or delayed dose. Ask whether any amount is an estimate, a pass-through pharmacy charge or a facility fee.
Use a first-30-days column as well as a normal-month column. The first period may include a partial room charge, pharmacy transition, clinical assessment and new supplies. Mark every item as confirmed, conditional or unresolved. A lower headline rate is not necessarily cheaper if it leaves a critical medication pathway undefined.
Keep clinical acceptance separate from drug coverage
Bridge eligibility does not require a nursing home to accept a resident, and a bed offer does not establish that the resident is clinically suitable for the program. The facility must review the complete care profile, including nutrition, mobility, kidney function, adverse-effect monitoring and the practical demands of the prescribed dosage form.
Ask the facility to state whether it can meet the resident's needs from the proposed admission date and what information could delay or prevent entry. The prescriber, Medicare program, pharmacy and facility each make different decisions. Do not treat a positive answer from one as a guarantee from the others.
Review the agreement and first invoice
The admission agreement and fee schedule should identify the room rate, covered services, pharmacy arrangements, optional charges, payment timing and responsibility for items not covered by Medicare or another payer. Match these documents to the answers about the GLP-1. If the contract refers generally to medications, ask for a written explanation of how this prescription will be billed and delivered.
Check who is signing and in what capacity. A relative coordinating placement should not casually become personally liable for medication or facility bills. If the provider requests a deposit, guarantee or broad payment undertaking, obtain independent legal or financial advice before signing.
Ask about placement commissions and pharmacy incentives
If an adviser, directory or placement service introduced the home, ask whether the facility pays a referral or marketing commission and whether non-paying facilities were considered. Also ask whether the facility or its operator has a financial relationship with the selected pharmacy. A relationship does not by itself make the arrangement unsuitable, but it can affect the option set and should be disclosed before comparison.
Verify coverage and pharmacy facts directly with Medicare, the drug plan, prescriber, pharmacy and facility. A paid introduction is not proof of stock, authorization, care fit or admission.
How Curalune can support the comparison
Curalune can select options using the resident's care needs, location, timing, pharmacy requirements and written cost logic. Its fuller contact service can ask chosen facilities about current beds, pharmacy workflow, administration, first-month charges and admission documents, then organize the answers into a comparable shortlist.
Curalune does not guarantee availability, Medicare or plan coverage, prior authorization, medication supply, clinical suitability or admission. The public program, prescriber, pharmacy and each facility retain their own decisions.
Frequently asked questions
Does the Medicare GLP-1 Bridge cover every GLP-1 drug?
No. Medicare lists specific products and dosage forms. Confirm the exact prescription and whether regular Part D coverage or the Bridge applies.
Does the $50 pharmacy copayment include nursing-home fees?
No. It is the Bridge copayment for a one-month supply. Request the facility's separate written rate and any medication-related charges.
Can a nursing home guarantee that prior authorization will be approved?
No. The prescriber submits required information and the program makes the coverage decision. The facility must separately confirm its pharmacy and administration workflow.
Can Curalune reserve a bed while the prescription is unresolved?
No. Curalune can help select options and contact facilities, but it cannot guarantee a reservation, medication supply, coverage or admission.